Aprea Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
0.15 | 48.77 | -99.69% | -7.57 | -101.98% |
| P/S |
|
22.64 | 33.76 | -32.93% |
|
|
| P/BV |
|
0.7229 | 4.82 | -85% |
|
|
| P/FCF |
|
-1.18 | 60.98 | -101.94% |
|
|
| Ev/Ebitda |
|
0.5433 | -22.12 | -102.46% |
|
|
| Ev/S |
|
-14.41 | 22.56 | -163.85% |
|
|
| Ev/FCF |
|
0.6848 | 68.75 | -99% |
|
|
| E/P |
|
-0.9853 | 0.0178 | -5643.59% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-2651.59 | 4.83 | -54994.23% | -883.86 | +200% |
| ROE |
|
-78.22 | 9.61 | -914.28% |
|
|
| ROA |
|
-63.08 | 0.3359 | -18877.81% |
|
|
| ROIC |
|
-62.51 | 7.63 | -918.8% |
|
|
| ROS |
|
-2449.59 | -25.17 | 9632.14% |
|
|
| ROCE |
|
-84.71 | 15.33 | -652.54% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0072 | -3.67 | -99.8% | -0.0032 | +125.06% |
| Nеt Debt/Ebitda |
|
1.4 | -3.44 | -140.63% |
|
|
| Debt/Ratio |
|
0.0049 | 0.1972 | -97.51% |
|
|
| Debt/Equity |
|
0.0037 | 1.65 | -99.78% |
|
|
| Debt/Net Income |
|
-0.0078 | 10.31 | -100.08% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% | ||
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
759.36 | -56.89 | -1434.79% | ||
| Growth impulse Ebitda in 5 years |
|
-47.35 | -64.81 | -26.94% | ||
| Growth impulse Net Income in 5 years |
|
-48.98 | -58.33 | -16.03% | ||
| Growth impulse FCF in 5 years |
|
-54.55 | -47 | 16.06% | ||
| Growth impulse EPS in 5 years |
|
-15.43 | -32.41 | -52.39% |
IP Score
3.6/10
